Search Orphan Drug Designations and Approvals
-
Generic Name: | Coagulation Factor VIIa (Recombinant) |
---|---|
Date Designated: | 10/03/2006 |
Orphan Designation: | Treatment of bleeding in patients experiencing intracranial hemorrhage. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 02/20/2014 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Novo Nordisk, Inc. P. O. Box 846 Plainsboro, New Jersey 08536 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-